Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aaafe3cbdd769c06240b0e90e9380e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_174979d8609af8bae325604135b8fe7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d55b44219a84c850812a4488def924 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
filingDate |
2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a1c5fd55d491c150de7bc79c64c230 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893b40bb16620c223377b2a78c662bf2 |
publicationDate |
2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009128533-A1 |
titleOfInvention |
Mesenchymal stem cell and method for production thereof |
abstract |
Disclosed is a method for producing a mesenchymal stem cell capable of being differentiated into a myoblast by culturing a pluripotent stem cell derived from a human body or an animal. The method comprises the following steps i) to iv): i) providing the pluripotent stem cell which has been cryopreserved; ii) subculturing the pluripotent stem cell for a predetermined number of times while keeping the pluripotent stem cell in an undifferentiated state; iii) culturing the subcultured pluripotent stem cell under conditions which enable the induction of the differentiation of the pluripotent stem cell into a fat cell in vitro ; and iv) separating and collecting a CD105-positive cell in the culturing step. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015107124-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5963670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011015662-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522281-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016525098-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968639-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013507981-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011136378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018193394-A |
priorityDate |
2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |